Literature DB >> 14615578

Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma.

Charles B Nemeroff1, Christine M Heim, Michael E Thase, Daniel N Klein, A John Rush, Alan F Schatzberg, Philip T Ninan, James P McCullough, Paul M Weiss, David L Dunner, Barbara O Rothbaum, Susan Kornstein, Gabor Keitner, Martin B Keller.   

Abstract

Major depressive disorder is associated with considerable morbidity, disability, and risk for suicide. Treatments for depression most commonly include antidepressants, psychotherapy, or the combination. Little is known about predictors of treatment response for depression. In this study, 681 patients with chronic forms of major depression were treated with an antidepressant (nefazodone), Cognitive Behavioral Analysis System of Psychotherapy (CBASP), or the combination. Overall, the effects of the antidepressant alone and psychotherapy alone were equal and significantly less effective than combination treatment. Among those with a history of early childhood trauma (loss of parents at an early age, physical or sexual abuse, or neglect), psychotherapy alone was superior to antidepressant monotherapy. Moreover, the combination of psychotherapy and pharmacotherapy was only marginally superior to psychotherapy alone among the childhood abuse cohort. Our results suggest that psychotherapy may be an essential element in the treatment of patients with chronic forms of major depression and a history of childhood trauma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14615578      PMCID: PMC283585          DOI: 10.1073/pnas.2336126100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  Childhood abuse, household dysfunction, and the risk of attempted suicide throughout the life span: findings from the Adverse Childhood Experiences Study.

Authors:  S R Dube; R F Anda; V J Felitti; D P Chapman; D F Williamson; W H Giles
Journal:  JAMA       Date:  2001-12-26       Impact factor: 56.272

2.  Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors.

Authors:  M E Thase; A R Entsuah; R L Rudolph
Journal:  Br J Psychiatry       Date:  2001-03       Impact factor: 9.319

Review 3.  The depressed suicidal patient. Assessment and treatment.

Authors:  C B Nemeroff; M T Compton; J Berger
Journal:  Ann N Y Acad Sci       Date:  2001-04       Impact factor: 5.691

4.  Childhood trauma associated with smaller hippocampal volume in women with major depression.

Authors:  Meena Vythilingam; Christine Heim; Jeffrey Newport; Andrew H Miller; Eric Anderson; Richard Bronen; Marijn Brummer; Lawrence Staib; Eric Vermetten; Dennis S Charney; Charles B Nemeroff; J Douglas Bremner
Journal:  Am J Psychiatry       Date:  2002-12       Impact factor: 18.112

5.  Gender differences in treatment response to sertraline versus imipramine in chronic depression.

Authors:  S G Kornstein; A F Schatzberg; M E Thase; K A Yonkers; J P McCullough; G I Keitner; A J Gelenberg; S M Davis; W M Harrison; M B Keller
Journal:  Am J Psychiatry       Date:  2000-09       Impact factor: 18.112

6.  How long should patients with psychotic depression stay on the antipsychotic medication?

Authors:  Anthony J Rothschild; Suzanne E Duval
Journal:  J Clin Psychiatry       Date:  2003-04       Impact factor: 4.384

7.  Stressful life events, genetic liability, and onset of an episode of major depression in women.

Authors:  K S Kendler; R C Kessler; E E Walters; C MacLean; M C Neale; A C Heath; L J Eaves
Journal:  Am J Psychiatry       Date:  1995-06       Impact factor: 18.112

8.  Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.

Authors:  R C Kessler; K A McGonagle; S Zhao; C B Nelson; M Hughes; S Eshleman; H U Wittchen; K S Kendler
Journal:  Arch Gen Psychiatry       Date:  1994-01

9.  Reports of the childhood home environment in early-onset dysthymia and episodic major depression.

Authors:  H Lizardi; D N Klein; P C Ouimette; L P Riso; R L Anderson; S K Donaldson
Journal:  J Abnorm Psychol       Date:  1995-02

Review 10.  The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment.

Authors:  D L Musselman; D L Evans; C B Nemeroff
Journal:  Arch Gen Psychiatry       Date:  1998-07
View more
  189 in total

1.  Association between early adverse life events and irritable bowel syndrome.

Authors:  Kara Bradford; Wendy Shih; Elizabeth J Videlock; Angela P Presson; Bruce D Naliboff; Emeran A Mayer; Lin Chang
Journal:  Clin Gastroenterol Hepatol       Date:  2011-12-16       Impact factor: 11.382

Review 2.  Gene-environment interaction in major depression and antidepressant treatment response.

Authors:  Robert Keers; Rudolf Uher
Journal:  Curr Psychiatry Rep       Date:  2012-04       Impact factor: 5.285

3.  Toward an Integration of Social and Biological Research.

Authors:  Vivia V McCutcheon
Journal:  Soc Serv Rev       Date:  2006-03

4.  Predictors of non-stabilization during the combination therapy of lithium and divalproex in rapid cycling bipolar disorder: a post-hoc analysis of two studies.

Authors:  Keming Gao; David E Kemp; Zuowei Wang; Stephen J Ganocy; Carla Conroy; Marry Beth Serrano; Martha Sajatovic; Robert L Findling; Joseph R Calabrese
Journal:  Psychopharmacol Bull       Date:  2010

Review 5.  Pharmacogenomics of suicidal events.

Authors:  David Brent; Nadine Melhem; Gustavo Turecki
Journal:  Pharmacogenomics       Date:  2010-06       Impact factor: 2.533

6.  Childhood maltreatment and social anxiety disorder: implications for symptom severity and response to pharmacotherapy.

Authors:  Laura C Bruce; Richard G Heimberg; Carlos Blanco; Franklin R Schneier; Michael R Liebowitz
Journal:  Depress Anxiety       Date:  2011-11-07       Impact factor: 6.505

7.  Affective status in relation to impulsive, motor and motivational symptoms: personality, development and physical exercise.

Authors:  Tomas Palomo; Richard J Beninger; Richard M Kostrzewa; Trevor Archer
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

8.  A shared effect of paroxetine treatment on gray matter volume in depressive patients with and without childhood maltreatment: A voxel-based morphometry study.

Authors:  Xiao-Wen Lu; Hua Guo; Jing-Rong Sun; Qiang-Li Dong; Fu-Tao Zhao; Xu-Hong Liao; Li Zhang; Yan Zhang; Wei-Hui Li; Ze-Xuan Li; Tie-Bang Liu; Yong He; Ming-Rui Xia; Ling-Jiang Li
Journal:  CNS Neurosci Ther       Date:  2018-09-12       Impact factor: 5.243

Review 9.  [Inpatient treatment of depression. Should one combine psychotherapy and drugs?].

Authors:  T J Huber
Journal:  Nervenarzt       Date:  2005-03       Impact factor: 1.214

10.  Hippocampal changes associated with early-life adversity and vulnerability to depression.

Authors:  Uma Rao; Li-Ann Chen; Anup S Bidesi; Mujeeb U Shad; M Albert Thomas; Constance L Hammen
Journal:  Biol Psychiatry       Date:  2009-12-16       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.